$26.32
1.11% yesterday
Nasdaq, Nov 14, 10:00 pm CET

STAAR Surgical Company Stock price

$26.32
-0.78 2.86% 1M
+8.89 51.00% 6M
+2.03 8.36% YTD
-0.98 3.57% 1Y
-38.26 59.24% 3Y
-52.99 66.81% 5Y
+18.09 219.81% 10Y
+20.87 382.94% 20Y
Nasdaq, Closing price Fri, Nov 14 2025
+0.29 1.11%

New AI Insights on STAAR Surgical Company Insights AI Insights on STAAR Surgical Company

How does the company make money?
Who are the company’s main competitors?

Key metrics

Basic
Market capitalization
$1.3b
Enterprise Value
$1.1b
Net debt
positive
Cash
$192.7m
Shares outstanding
49.4m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
5.7 | 5.0
EV/Sales
4.8 | 4.3
EV/FCF
negative
P/B
3.7
Financial Health
Equity Ratio
78.0%
Return on Equity
-5.1%
ROCE
-15.9%
ROIC
-28.3%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$230.6m | $260.4m
EBITDA
$-54.2m | $-18.4m
EBIT
$-62.9m | $-79.7m
Net Income
$-96.4m | $-61.6m
Free Cash Flow
$-39.5m
Growth (TTM | estimate)
Revenue
-32.4% | -17.0%
EBITDA
-272.5% | -175.4%
EBIT
-344.8% | -629.4%
Net Income
-542.5% | -204.9%
Free Cash Flow
-250.3%
Margin (TTM | estimate)
Gross
73.9%
EBITDA
-23.5% | -7.1%
EBIT
-27.3%
Net
-41.8% | -23.7%
Free Cash Flow
-17.2%
More
EPS
$-1.9
FCF per Share
$-0.8
Short interest
13.7%
Employees
1k
Rev per Employee
$270.0k
Show more

Is STAAR Surgical Company a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,042 stocks worldwide.

STAAR Surgical Company Stock Analysis

Unlock Scores for Free

Analyst Opinions

14 Analysts have issued a STAAR Surgical Company forecast:

11x Hold
79%
3x Sell
21%

Analyst Opinions

14 Analysts have issued a STAAR Surgical Company forecast:

Hold
79%
Sell
21%

Financial data from STAAR Surgical Company

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
231 231
32% 32%
100%
- Direct Costs 60 60
17% 17%
26%
170 170
37% 37%
74%
- Selling and Administrative Expenses 188 188
1% 1%
82%
- Research and Development Expense 45 45
14% 14%
20%
-54 -54
273% 273%
-24%
- Depreciation and Amortization 8.69 8.69
52% 52%
4%
EBIT (Operating Income) EBIT -63 -63
345% 345%
-27%
Net Profit -96 -96
542% 542%
-42%

In millions USD.

Don't miss a Thing! We will send you all news about STAAR Surgical Company directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

STAAR Surgical Company Stock News

Neutral
Business Wire
5 days ago
NEW YORK--(BUSINESS WIRE)--Broadwood Partners, L.P. and its affiliates (collectively, “Broadwood”) today commented on the recent filing of amendments to the merger agreement in connection with the proposed sale of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA) to Alcon Inc. (“Alcon”) (NYSE: ALC). Neal C. Bradsher, Founder and President of Broadwood, said: “For more than three ...
Neutral
Business Wire
8 days ago
LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced that the Company has agreed with Alcon Inc. (SIX/NYSE: ALC) to amend their merger agreement to allow proactive solicitation by STAAR of third-party proposals to maximize value for all S...
Neutral
Business Wire
9 days ago
HONG KONG--(BUSINESS WIRE)--Yunqi Capital Applauds STAAR Surgical's Strong Third Quarter Results and Reiterates That the Proposed Sale to Alcon Should Be Terminated.
More STAAR Surgical Company News

Company Profile

STAAR Surgical Co. engages in the development, manufacture, production, marketing, and sale of implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. It specializes in refractive and cataract solutions. Its products include intraocular lens and implantable collamer lens. The company was founded in 1982 and is headquartered in Lake Forest, CA.

Head office United States
CEO Stephen Farrell
Employees 1,157
Founded 1982
Website www.staar.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today